SARAH WILSON: Open Payments
NPI 1427468057 · MANCHESTER, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 37 payments from 15 companies in 2025. Trend: 2023 $978 · 2024 $1,033 · 2025 $658
Food & beverage: $658
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $146 |
| Abbott Laboratories | 4 | $96 |
| ABBVIE INC. | 4 | $90 |
| Astellas Pharma US Inc | 4 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
Products named: FREESTYLE LIBRE 3, Veozah, VRAYLAR, Wegovy, CAPLYTA, Ozempic, REXULTI, Auvelity.
Industry payments across TN — which companies pay providers there.
